Literature DB >> 30743195

Associations between drug use patterns and viral load suppression among HIV-positive individuals who use support services in New York City.

Matthew B Feldman1, Kelsey L Kepler2, Mary K Irvine2, Jacinthe A Thomas2.   

Abstract

BACKGROUND: Drug use (DU) represents a significant barrier to maintaining physical health among people living with HIV (PLWH). Few studies, however, have examined the relationship between DU over time and HIV treatment outcomes. Such studies are needed because an individual's risk of poor health outcomes may vary with their DU behaviors. We examined associations between DU patterns over time and unsuppressed viral load (VL).
METHODS: The sample included 7896 PLWH in New York City who completed ≥3 substance use assessments over a 24-month period. DU was defined as crystal methamphetamine, crack/cocaine, heroin, and/or recreational prescription medication use in the last three months. Four behavior patterns were constructed: (1) persistent use (DU reported on each assessment); (2) intermittent use-active (DU reported on the third, but not all previous assessments); (3) intermittent use-inactive (DU reported previously with no DU reported on the third assessment); (4) persistent non-use (no DU reported on any assessment). Unsuppressed VL (>200 copies/mL) was assessed based on the last VL value in the New York City HIV Surveillance Registry in the 12 months following an individual's third DU assessment.
RESULTS: Compared with persistent non-users, individuals with intermittent use-inactive (aOR = 1.24, 95% CI = 1.03-1.49), intermittent use-active (aOR = 1.68, 95% CI = 1.36-2.06), and persistent use (aOR = 2.21, 95% CI = 1.69-2.89) were significantly more likely to have unsuppressed VL.
CONCLUSIONS: While providers may be more likely to intervene with persistent or active drug users, our findings suggest the importance of addressing the risk of poor HIV treatment outcomes among those with any DU behavior.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug use; HIV; Patterns; Viral load suppression

Mesh:

Substances:

Year:  2019        PMID: 30743195     DOI: 10.1016/j.drugalcdep.2018.12.015

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  8 in total

1.  Serving the Co-Morbid Mental Health and Substance Use Needs of People with HIV.

Authors:  Fiona N Conway; Michele A Rountree; Kristian V Jones
Journal:  Community Ment Health J       Date:  2021-01-02

2.  High Levels of Syndemics and Their Association with Adherence, Viral Non-suppression, and Biobehavioral Transmission Risk in Miami, a U.S. City with an HIV/AIDS Epidemic.

Authors:  Tiffany R Glynn; Steven A Safren; Adam W Carrico; Noelle A Mendez; Lunthita M Duthely; Sannisha K Dale; Deborah L Jones; Daniel J Feaster; Allan E Rodriguez
Journal:  AIDS Behav       Date:  2019-11

3.  Moderating effects of social support on the relationship between substance use disorders and HIV viral load and medication adherence among Black women living with HIV in the United States.

Authors:  Rachelle Reid; Sannisha K Dale
Journal:  AIDS Care       Date:  2021-11-16

4.  Methamphetamine Injection Among Young Men Who Have Sex With Men: Risk for Human Immunodeficiency Virus Transmission in a Los Angeles Cohort.

Authors:  Pamina M Gorbach; Marjan Javanbakht; Amy Ragsdale; Robert B Bolan; Risa Flynn; Raul Mandler; Steven Shoptaw
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

5.  Polysubstance use and adherence to antiretroviral treatment in the Miami Adult Studies on HIV (MASH) cohort.

Authors:  Abraham Degarege; Karl Krupp; Javier Tamargo; Sabrina Sales Martinez; Adriana Campa; Marianna Baum
Journal:  AIDS Care       Date:  2021-03-05

Review 6.  mHealth Interventions to Promote Anti-Retroviral Adherence in HIV: Narrative Review.

Authors:  Stephen B Lee; Joanne Valerius
Journal:  JMIR Mhealth Uhealth       Date:  2020-08-28       Impact factor: 4.773

Review 7.  An update on drug-drug interactions between antiretroviral therapies and drugs of abuse in HIV systems.

Authors:  Nuti Desai; Leah Burns; Yuqing Gong; Kaining Zhi; Asit Kumar; Nathan Summers; Santosh Kumar; Theodore J Cory
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-08-31       Impact factor: 4.481

8.  Methamphetamine Induces the Release of Proadhesive Extracellular Vesicles and Promotes Syncytia Formation: A Potential Role in HIV-1 Neuropathogenesis.

Authors:  Subhash Chand; Catherine DeMarino; Austin Gowen; Maria Cowen; Sarah Al-Sharif; Fatah Kashanchi; Sowmya V Yelamanchili
Journal:  Viruses       Date:  2022-03-07       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.